The Asia Dengue Policy Working Group, launched in April 2024, is the first Working Group under the Asia Dengue Task Force. The Policy Working Group strives to unite diverse stakeholders, provide a platform to foster dialogue, build consensus, identify strategies to improve dengue outcomes, and achieve the World Health Organization's (WHO) goal of Zero Dengue Deaths by 2030.
We aim to increase the priority of dengue surveillance, prevention, treatment, case management, and control at the regional, national, and sub-national levels.
We firmly believe in the impact of collaboration and concerted action to instigate positive change. With this conviction, the Asia Dengue Policy Working Group aims to foster collaboration between diverse stakeholders from the public and private sectors to advocate for effective policies to improve surveillance, prevention, treatment, case management, and control of dengue, thereby strengthening healthcare systems.
The Asia Dengue Policy Working Group aims to facilitate discussions among relevant stakeholders, sharing key insights, recommendations, and effective strategies to enact change and combat dengue across the region. This is achieved through activities such as policy mapping, crafting of white papers, and hosting webinars and roundtables.
Detailed information regarding the Policy Working Group’s activities will be disclosed in due time.
Following a temporary decrease in cases globally from 2020-2022 owing to the COVID-19 pandemic and reduced reporting, there has been a resurgence in dengue cases worldwide marked by a substantial increase in both the number and scale of outbreaks, spreading into regions previously unaffected by dengue. Ongoing transmission and an unexpected spike in cases have led to nearly record-high levels, with over 5 million cases and more than 5,000 dengue-related deaths reported, globally.
Indonesia, Myanmar, and Thailand rank among the world’s 30 most highly endemic countries.
Bangladesh and Thailand have seen significant increases in dengue cases compared to previous years, with reported cases reaching 308,167 and 136,655, respectively (as of November 2023). During this period, the death toll in Bangladesh rose to 1,598, while in Thailand, it reached 147 deaths.
The Philippines and Vietnam are the most affected, reporting 167,355 cases and 575 deaths, and 149,577 cases and 36 deaths, respectively (as of December 2023).
Interested in joining as a member? Sign up here:
If you would like to learn more about us or join our efforts to improve dengue outcomes, please contact us.
Asia Dengue Voice and Action (ADVA) is a scientific working group dedicated to dengue vaccine advocacy in Asia, with the aim of disseminating information and making recommendations on dengue vaccine introduction strategies in Asia.
Vista Health, a global value-based healthcare agency, offers strategic consulting and tech-enabled solutions across all sectors of healthcare. As the Strategy & Operations Partner, it leads the strategic direction and vision, and undertakes critical activities and administration related to the Asia Dengue Policy Working Group.